Showing results (361-370 of 370) with videos related to

Sort By:
Pageof 37
You have reached the last page of results.This site can display upto 370 results.
Scientific Reports|March 8, 2019
Efficient recycling of nutrients in modern and past hypersaline environmentsY Isaji, H Kawahata, N O Ogawa, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|November 24, 1999
[An early phase II study of autologous peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission. Japan Blood Cell Transplantation Study Group]F Kawano, T Kiyokawa, K Shinagawa, et al.
Diabetes|May 20, 1999
Association of polymorphism in the NeuroD/BETA2 gene with type 1 diabetes in the JapaneseI Iwata, S Nagafuchi, H Nakashima, et al.
American Journal of Hematology|November 26, 2002
Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative studyK Tamura, H Matsuoka, J Tsukada, et al.
Bone Marrow Transplantation|October 26, 2005
Demonstration of reversed flow in segmental branches of the portal vein with hand-held color Doppler ultrasonography after hematopoietic stem cell transplantationM Hashiguchi, T Okamura, K Yoshimoto, et al.
Bone Marrow Transplantation|February 1, 1997
Increased incidence of cytomegalovirus (CMV) infection and CMV-associated disease after allogeneic bone marrow transplantation from unrelated donors. The Fukuoka Bone Marrow Transplantation GroupK Takenaka, H Gondo, K Tanimoto, et al.
Bone Marrow Transplantation|August 28, 2003
Influence of transplanted dose of CD56+ cells on development of graft-versus-host disease in patients receiving G-CSF-mobilized peripheral blood progenitor cells from HLA-identical sibling donorsS Yamasaki, H Henzan, Y Ohno, et al.
Bone Marrow Transplantation|December 24, 1997
Autologous peripheral blood stem cell transplantation for acute myelogenous leukemiaH Gondo, M Harada, T Miyamoto, et al.
The Japanese Journal of Antibiotics|December 1, 1996
[Comparison between monotherapy with imipenem/cilastatin sodium (IPM/CS) and combinations of IPM/CS and other drugs for treating bacterial infections in patients with hematopoietic disorders]Y Sawae, Y Niho, T Okamura, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Incidence, risk factors, and clinical implications of enfortumab vedotin-related cutaneous toxicity in urothelial carcinoma: a large-scale, real-world study in JapanY Kita, T Hara, T Kawahara, et al.
Pageof 37